PLAUR and breast cancer: For the first time, we also propose a regulatory signaling model as a mechanism responsible for maintaining the aggressive properties of primary and DTCs, through high co-expression of HER2 and uPA receptors and use it as a rationale to highlight the importance of simultaneously targeting HER2 and uPAR in advanced BC.